Our Portfolio

At Horizon, we’re driven by a clear purpose; to improve patients’ lives.

And the clearest expression of that purpose is the portfolio of medicines we offer to address unmet medical needs. We market our medicines through our orphan, rheumatology and primary care business units.

Follow the links below to explore our medicines.

Medicines Marketed in the United States

In the United States, report an adverse event or side effect:

Please click below to see the Full U.S. Prescribing Information, including Boxed Warning where applicable and Medication Guide Information for:

To view a list of medicines marketed in Canada, please visit horizontherapeutics.ca.

At this time, we do not have any investigational uses of our medicines that require or necessitate an Expanded Access Program. It is our intention to comply fully with the 21st Century Cures Act when and where applicable to our medicines. Please check back periodically for any updates or changes. For additional information, please contact medicalinformation@horizonpharma.com.